Authors
Latest:
A Close Look at Flexible Dosing Strategies for Atopic Dermatitis in Adults with Raj Chovatiya, MD, PhD, MSCIRAD 2025: Chovatiya toplines shifts in dosing strategies for topical, oral, and injectable AD therapy observed in both clinical trials and clinical practice.
Latest:
The Future of Multi-Cancer Early DetectionTo close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
Patient Selection for Lecanemab to Treat Early Alzheimer Dementia: Details with R Scott Turner, PhD, MDDr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.
Latest:
New ACP Guidelines on Prevention of Episodic Migraine Cite Lack of Comparative Evidence for TreatmentsPharmacologic treatment to prevent episodic migraine should follow a sequential trial approach that considers medication cost, headache triggers, adherence, and lifestyle interventions.
Latest:
Women’s Health Takeaways for Primary Care: Expert Insights from ACOG 2025Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Latest:
Cannabis Legalization and Prenatal Marijuana Use: Pregnant Women Describe ImpactNew research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.
Latest:
Novel Non-Invasive Glucose Monitor Uses Light-Based TechnologyAccuracy of data recorded with the GlucoBeam was found to be comparable to standard finger-stick blood glucose tests.
Latest:
Breast Cancer Rehab and Primary Care, with PM&R Specialist Sean Smith, MDBreast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.
Latest:
Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New DataAfter 60 months of treatment, 38% of study participants with severe AD achieved complete remission.
Latest:
Clinical Pearls from 2025 ACP Internal Medicine MeetingExpert insights on PAD prevention, boosting colon cancer screening, and expanding obesity treatment options.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
The Superbug Challenge: Medicine's Essential Fight Against Antimicrobial ResistanceA medical director of antimicrobial stewardship at a large metropolitan health system highlights the dangers of AMR and how she believes the pharmaceutical industry could help.
Latest:
Expert Panel Offers Guidance on Testing for COVID-19, Influenza, RSV During Respiratory Virus Season 2023-2024As flu season approaches this year, experts stress that it's not just about influenza anymore; they discuss testing, antiviral treatment, and management of coinfection.
Latest:
Clinical Implications of Off Target TSH Levels and Importance of Patient Education in Managing HypothyroidismEndocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
It's High Time to Normalize Pre-Visit Lab TestingResearch demonstrates that discussing test results face-to-face with patients during office visits is beneficial for patient and clinician, according to family physician Andrew Carroll, MD.
Latest:
For Alzheimer Agitation, a Novel, Oral NMDA Inhibitor Could be the Next Targeted TreatmentGeriatric psychiatrist and neurocognitive researcher George Grossberg, MD, highlights the mechanism of action for the new dextromethorphan/bupropion combination.
Latest:
Racial Disparities Persist in Respiratory Disease Research, Diagnostics: Expert Panel Discussion at 2024 ATSPulmonology experts agreed that adopting race-neutral diagnostic and research practices could help mitigate a range of inequities faced by minority populations.
Latest:
Why is Wound Care Falling to Primary Care?Overscheduled and undertrained, primary care clinicians shoulder a significant portion of the US wound care burden. Author Nima Ahmadi offers a technology-based solution.
Latest:
Obesity and the Musculoskeletal System: Age and ImpactExcess weight diminishes the development and function of the musculoskeletal system at any point in the lifespan. An obesity specialist highlights the dangers.
Latest:
Navigating Hypoglycemia Challenges Associated with Dumping SyndromeThe expert panel concludes by examining strategies for managing hypoglycemia challenges related to dumping syndrome, particularly in the context of continuous glucose monitoring use.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage ListUpdate: The FDA has told compounding pharmacies they may resume production of tirzepatide products while the agency further investigates supply.
Latest:
RFK Jr Ends COVID-19 Vaccine Recommendation for Healthy Children, Pregnant WomenHHS Secretary Kennedy announced the CDC will no longer recommend vaccination against infection with SARS-CoV-2 for the 2 vulnerable populations.
Latest:
Hey Doc: Use or Lose those Vacation DaysVacation behavior among US physicians was found wanting, with more than half taking less than 15 days/year, 20% taking ≤5 days, and 70% working on their time off.
Latest:
Semaglutide Cuts Cardiovascular Risk by 20% in Adults with Obesity, CVD and Without DiabetesAHA 2023: Semaglutide 2.4 mg reduced the risk of serious cardiovascular events by 20% in patients with obesity and overweight with established CVD but without diabetes, according to full SELECT trialresults.
Latest:
Lung Cancer Survival Improved Significantly Based on Early CT Screening: 20-Year Follow-Up Study FindingsEarly CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.
Latest:
Final Thoughts on Strategies for Managing and Monitoring Patients Receiving TeplizumabThe panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
